NDC 51662-1247

PROMETHAZINE HCI

Promethazine Hci

PROMETHAZINE HCI is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Healthfirst. The primary component is Promethazine Hydrochloride.

Product ID51662-1247_7447e8c6-c199-cd2d-e053-2a91aa0a3895
NDC51662-1247
Product TypeHuman Prescription Drug
Proprietary NamePROMETHAZINE HCI
Generic NamePromethazine Hci
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2018-08-26
Marketing CategoryANDA / ANDA
Application NumberANDA083312
Labeler NameHF Acquisition Co. LLC, DBA HealthFirst
Substance NamePROMETHAZINE HYDROCHLORIDE
Active Ingredient Strength25 mg/mL
Pharm ClassesPhenothiazine [EPC],Phenothiazines [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1247-1

1 mL in 1 VIAL, SINGLE-DOSE (51662-1247-1)
Marketing Start Date2018-08-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1247-1 [51662124701]

PROMETHAZINE HCI INJECTION
Marketing CategoryANDA
Application NumberANDA083312
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-26
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
PROMETHAZINE HYDROCHLORIDE25 mg/mL

OpenFDA Data

SPL SET ID:7447e8c6-c198-cd2d-e053-2a91aa0a3895
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 992460
  • Pharmacological Class

    • Phenothiazine [EPC]
    • Phenothiazines [CS]

    NDC Crossover Matching brand name "PROMETHAZINE HCI" or generic name "Promethazine Hci"

    NDCBrand NameGeneric Name
    51662-1247PROMETHAZINE HCIPROMETHAZINE HCI
    51662-1248PROMETHAZINE HCIPROMETHAZINE HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.